Reassessment of CXCR4 Chemokine Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-2
Thomas Fischer, Falko Nagel, Stefan Jacobs et al. · 2008
Read Reassessment of CXCR4 Chemokine Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-2 by Thomas Fischer, Falko Nagel, Stefan Jacobs et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004069.txt.
Description
Thomas Fischer, Falko Nagel, Stefan Jacobs, and co-authors rechecked a cancer receptor measure in 2008. CXCR4 is a chemokine receptor that steers cell migration. It guides cancer cells toward specific sites where they seed metastases. Knowing a tumor's CXCR4 status could predict its course.
Earlier attempts to locate the receptor in tissue proved unreliable. Their PLOS ONE article validates a new rabbit antibody called UMB-2. With it, they reassessed normal and tumor tissues. A trustworthy stain is the first step toward CXCR4-guided therapy choices. The paper came out in PLOS ONE, an open journal for work in science and health.
Catalog record
| CREATOR | Thomas Fischer, Falko Nagel, Stefan Jacobs et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004069